BackTable Tumor Board
BackTable Tumor Board
Podcast Description
BackTable Tumor Board is a multi-disciplinary podcast for healthcare professionals that play an active role in cancer care. Season One features in-depth conversations on the topic of Hepatocellular Carcinoma (HCC) provided by a group of medical oncologists, interventional radiologists, hepatobiliary surgeons, hepatologists, and patient coordinators. Stay tuned for the next season!
Podcast Insights
Content Themes
The podcast explores various aspects of hepatocellular carcinoma, including treatment options, complex case discussions from tumor board meetings, and insights on the role of surgery, interventional oncology, and transplantation. Episodes feature detailed case reviews, such as the principles of practice in HCC tumor boards and tips for starting a career in interventional oncology.
BackTable Tumor Board is a multi-disciplinary podcast for healthcare professionals that play an active role in cancer care.
Why might the standard RECIST criteria fail to accurately track success after tumor ablation, and what should you look for instead? In the 4th installment of the 2025 NSCLC Cancer Creator Weekend™ series, hosts Drs. Scott Genshaft and Kavi Krishnasamy are joined by specialists from UCLA and USC to discuss and debate advanced treatment options for primary lung cancer.
—
This podcast is supported by an educational grant from Johnson & Johnson and Varian.
—
SYNPOSIS
The panel, including interventional radiologists, pulmonologists, and a radiation oncologist, discusses the intricacies of photon versus proton therapies, the physics behind radiation treatment, and the evolving landscape of ablation technologies. The conversation covers the efficacy and limitations of different treatments, patient selection criteria, and the role of newer technologies like electroporation and robotic-assisted bronchoscopy in enhancing precision and outcomes. Additionally, the panel addresses the practical challenges of intraprocedural imaging, the importance of adequate margins, and the complexities of managing local recurrences and radiation-induced toxicities.
—
TIMESTAMPS
00:00 – Tumor Ablation and Recurrence Rates
12:53 – Advancements in Ablation Technologies
23:31 – Bronchoscopic Approaches in Lung Cancer Treatment
38:46 – Challenges in Radiation Dose and Delivery
49:21 – Ablation and Radiation Margins
01:07:19 – Final Thoughts
—
RESOURCES
Thierry de Baere Paper on Ablation Margins https://pmc.ncbi.nlm.nih.gov/articles/PMC9815739/
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.